Is it possible to estimate the incidence of breast cancer from medico-administrative databases?

European Journal of Epidemiology
L RemontetM Colonna

Abstract

One approach to estimate cancer incidence in the French Départements is to quantify the relationship between data in cancer registries and data obtained from the PMSI (Programme de Médicalisation des Systèmes d'Information Médicale). This relationship may then be used in Départements without registries to infer the incidence from local PMSI data. We present here some methodological solutions to apply this approach. Data on invasive breast cancer for 2002 were obtained from 12 Départemental registries. The number of hospital stays was obtained from the National PMSI using two different algorithms based on the main diagnosis only (Algorithm 1) or on that diagnosis associated to a mention of "resection" (Algorithm 2). Considering registry data as gold standard, a calibration approach was used to model the ratio of the number of hospital stays to the number of incident cases. In Départements with registries, validation of the predictions was done through cross-validation. In Départements without registries, validation was done through a study of homogeneity of the mean number of hospital stays per patient. Cross-validation showed that the estimates predicted by the model were true with data extracted by Algorithm 1 but not by Algor...Continue Reading

References

Jan 15, 1993·American Journal of Epidemiology·A M McBeanJ L Warren
Feb 1, 1997·American Journal of Epidemiology·D K McClishS Retchin
Jul 6, 2000·Journal of Clinical Epidemiology·J L FreemanJ S Goodwin
Jun 19, 2001·Cancer Causes & Control : CCC·P S WangJ Avorn
Sep 25, 2002·Cancer Detection and Prevention·Gregory S CooperAlfred A Rimm
Dec 14, 2002·Accident; Analysis and Prevention·Andrew P Jones, Stig H Jørgensen
Jul 29, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·O GanryA Dubreuil
Oct 10, 2006·International Journal for Equity in Health·Moyra E BrackleyMary L Lesperance
Jun 13, 2008·Revue D'épidémiologie Et De Santé Publique·A BelotM Velten
Dec 17, 2008·Journal of Clinical Epidemiology·Chantal Marie CourisBeatrice Trombert

❮ Previous
Next ❯

Citations

Jul 14, 2012·Journal of Cancer Epidemiology·C QuantinA Danzon
Feb 19, 2011·Journal of Clinical Epidemiology·Anne A ChantryUNKNOWN GRACE study group
Nov 18, 2008·Revue D'épidémiologie Et De Santé Publique·M ColonnaUNKNOWN le réseau Francim
Apr 30, 2011·Journal of Cancer Epidemiology·Nicolas MittonLaurent Remontet
Oct 15, 2010·Pharmacoepidemiology and Drug Safety·Alain WeillHubert Allemand
May 12, 2012·Revue D'épidémiologie Et De Santé Publique·A A ChantryUNKNOWN pour le groupe GRACE
Aug 18, 2009·Revue D'épidémiologie Et De Santé Publique·Z UhryM Colonna
Nov 19, 2011·Clinical Oral Implants Research·Kuang-Ta YaoMing-Lun Hsu
Jan 1, 2014·The European Physical Journal. C, Particles and Fields·O BuchmuellerG Weiglein
Feb 9, 2017·International Journal of Epidemiology·Thierry Boudemaghe, Ihssen Belhadj

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.